source
- Merck KGaA sells its CDMO business and US sites to LonzaMerck KGaA announced it will divest its contract development and manufacturing organization (CDMO) operations, transferring ownership of five U.S. manufacturing facilities to Lonza. The transactio…
- Compass Pathways leads race for first psychedelic drug approval, non-profit rivalsCompass Pathways is widely viewed as a leading candidate to bring the first psychedelic medicine to market. The company has advanced its therapy through clinical development and is positioned near…